About the Authors

Praveen Papareddy

Affiliation Division of Dermatology and Venereology, Department of Clinical Sciences, Lund University, Biomedical Center, Lund, Sweden

Victoria Rydengård

Affiliation Division of Dermatology and Venereology, Department of Clinical Sciences, Lund University, Biomedical Center, Lund, Sweden

Mukesh Pasupuleti

Affiliation Division of Dermatology and Venereology, Department of Clinical Sciences, Lund University, Biomedical Center, Lund, Sweden

Björn Walse

Affiliation SARomics AB, Lund, Sweden

Matthias Mörgelin

Affiliation Division of Infection Medicine, Department of Clinical Sciences, Lund University, Biomedical Center, Lund, Sweden

Anna Chalupka

Affiliations Division of Dermatology and Venereology, Department of Clinical Sciences, Lund University, Biomedical Center, Lund, Sweden, Department of Microbiology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Kraków, Poland

Martin Malmsten

Affiliation Department of Pharmacy, Uppsala University, Biomedical Center, Uppsala, Sweden

Artur Schmidtchen

artur.schmidtchen@med.lu.se

Affiliation Division of Dermatology and Venereology, Department of Clinical Sciences, Lund University, Biomedical Center, Lund, Sweden

Competing Interests

Drs. Schmidtchen and Malmsten have shares in DermaGen AB and XImmune AB, companies involved in the therapeutic development of peptides for topical and systemic use, respectively.

Author Contributions

Conceived and designed the experiments: P. Papareddy, M. Malmsten, A. Schmidtchen. Performed the experiments: P. Papareddy, V. Rydengård, M. Pasupuleti, M. Mörgelin, A. Chalupka, M. Malmsten. Analyzed the data: P. Papareddy, V. Rydengård, B. Walse, M. Mörgelin, M. Malmsten, A. Schmidtchen. Contributed reagents/materials/analysis tools: A. Schmidtchen. Wrote the paper: A. Schmidtchen.